Disruption of the Neuregulin 1 Gene in the Rat Alters HPA Axis Activity and Behavioral Responses to Environmental Stimuli

Overview

Journal Physiol Behav

Specialties Physiology
Psychiatry
Psychology
Social Sciences

Date 2010 Nov 25

PMID 21092742

Citations 14

Authors

S B Taylor

A R Taylor

J A Markham

A M Geurts

B Z Kanaskie

J I Koenig

Affiliations

Soon will be listed here.

Abstract

Exposure to stress can result in an increased risk for psychiatric disorders, especially among genetically predisposed individuals. Neuregulin 1 (NRG1) is a susceptibility gene for schizophrenia and is also associated with psychotic bipolar disorder. In the rat, the neurons of the hypothalamic paraventricular nucleus show strong expression of Nrg1 mRNA. In patients with schizophrenia, a single nucleotide polymorphism in the 5' region of NRG1 interacts with psychosocial stress to affect reactivity to expressed emotion. However, there is virtually no information on the role of NRG1 in hypothalamic-pituitary-adrenal axis function, and whether the protein is expressed in the paraventricular nucleus is unknown. The present studies utilize a unique line of Nrg1 hypomorphic rats (Nrg1(Tn)) generated by gene trapping with the Sleeping Beauty transposon. We first established that the Nrg1(Tn) rats displayed reduced expression of both the mRNA and protein corresponding to the Type II NRG1 isoform. After confirming, using wild type animals, that Type II NRG1 is expressed in the neurocircuitry involved in regulating hypothalamic-pituitary-adrenal axis responses to environmental stimuli, the Nrg1(Tn) rats were then used to test the hypothesis that altered expression of Type II NRG1 disrupts stress regulation and reactivity. In support of this hypothesis, Nrg1(Tn) rats have disrupted basal and acute stress recovery corticosterone secretion, differential changes in expression of glucocorticoid receptors in the pituitary, paraventricular nucleus and hippocampus, and a failure to habituate to an open field. Together, these findings point to NRG1 as a potential novel regulator of neuroendocrine responses to stress as well as behavioral reactivity.

Citing Articles

Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Szpirer C J Biomed Sci. 2020; 27(1):84.

PMID: 32741357 PMC: 7395987. DOI: 10.1186/s12929-020-00673-8.

Epigenetic meta-analysis across three civilian cohorts identifies NRG1 and HGS as blood-based biomarkers for post-traumatic stress disorder.

Uddin M, Ratanatharathorn A, Armstrong D, Kuan P, Aiello A, Bromet E Epigenomics. 2018; 10(12):1585-1601.

PMID: 30456986 PMC: 6331697. DOI: 10.2217/epi-2018-0049.

Epigenetic Programming of Synthesis, Release, and/or Receptor Expression of Common Mediators Participating in the Risk/Resilience for Comorbid Stress-Related Disorders and Coronary Artery Disease.

Del Campo C, Martinez-Rosas M, Guarner-Lans V Int J Mol Sci. 2018; 19(4).

PMID: 29670001 PMC: 5979500. DOI: 10.3390/ijms19041224.

Neuregulin 1 Deficiency Modulates Adolescent Stress-Induced Dendritic Spine Loss in a Brain Region-Specific Manner and Increases Complement 4 Expression in the Hippocampus.

Clarke D, Chohan T, Kassem M, Smith K, Chesworth R, Karl T Schizophr Bull. 2018; 45(2):339-349.

PMID: 29566220 PMC: 6403066. DOI: 10.1093/schbul/sby029.

Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.

Silveira M, Arnold J, Laviolette S, Hillard C, Celorrio M, Aymerich M Neurosci Biobehav Rev. 2016; 76(Pt B):380-395.

PMID: 27639448 PMC: 5350061. DOI: 10.1016/j.neubiorev.2016.09.007.

References

Shamir A, Buonanno A . Molecular and cellular characterization of Neuregulin-1 type IV isoforms. J Neurochem. 2010; 113(5):1163-76. PMC: 2931268. DOI: 10.1111/j.1471-4159.2010.06677.x. View

Koenig J, Elmer G, Shepard P, Lee P, Mayo C, Joy B . Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav Brain Res. 2004; 156(2):251-61. DOI: 10.1016/j.bbr.2004.05.030. View

Uchida S, Nishida A, Hara K, Kamemoto T, Suetsugi M, Fujimoto M . Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur J Neurosci. 2008; 27(9):2250-61. DOI: 10.1111/j.1460-9568.2008.06218.x. View

Mei L, Xiong W . Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci. 2008; 9(6):437-52. PMC: 2682371. DOI: 10.1038/nrn2392. View

Vahl T, Ulrich-Lai Y, Ostrander M, Dolgas C, Elfers E, Seeley R . Comparative analysis of ACTH and corticosterone sampling methods in rats. Am J Physiol Endocrinol Metab. 2005; 289(5):E823-8. DOI: 10.1152/ajpendo.00122.2005. View

Harrison P, Law A . Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry. 2006; 60(2):132-40. DOI: 10.1016/j.biopsych.2005.11.002. View

Pariante C . Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Ann N Y Acad Sci. 2009; 1179:144-52. PMC: 2982725. DOI: 10.1111/j.1749-6632.2009.04978.x. View

Herman J, Figueiredo H, Mueller N, Ulrich-Lai Y, Ostrander M, Choi D . Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol. 2003; 24(3):151-80. DOI: 10.1016/j.yfrne.2003.07.001. View

Dhabhar F, Miller A, McEwen B, Spencer R . Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fischer 344, and Lewis rats. J Neuroimmunol. 1995; 56(1):77-90. DOI: 10.1016/0165-5728(94)00135-b. View

10.

Falls D . Neuregulins and the neuromuscular system: 10 years of answers and questions. J Neurocytol. 2004; 32(5-8):619-47. DOI: 10.1023/B:NEUR.0000020614.83883.be. View

11.

Spencer R, Kim P, Kalman B, Cole M . Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology. 1998; 139(6):2718-26. DOI: 10.1210/endo.139.6.6029. View

12.

Silverman J, Koenig J . Evidence for the involvement of ERbeta and RGS9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior. Horm Behav. 2007; 52(2):146-55. PMC: 2096711. DOI: 10.1016/j.yhbeh.2007.03.017. View

13.

de Kloet E, Vreugdenhil E, Oitzl M, Joels M . Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998; 19(3):269-301. DOI: 10.1210/edrv.19.3.0331. View

14.

Dean B, Karl T, Pavey G, Boer S, Duffy L, Scarr E . Increased levels of serotonin 2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice. Schizophr Res. 2007; 99(1-3):341-9. DOI: 10.1016/j.schres.2007.10.013. View

15.

Boucher A, Arnold J, Duffy L, Schofield P, Micheau J, Karl T . Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. Psychopharmacology (Berl). 2007; 192(3):325-36. DOI: 10.1007/s00213-007-0721-3. View

16.

Willner P . Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology. 2005; 52(2):90-110. DOI: 10.1159/000087097. View

17.

Keri S, Kiss I, Seres I, Kelemen O . A polymorphism of the neuregulin 1 gene (SNP8NRG243177/rs6994992) affects reactivity to expressed emotion in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2008; 150B(3):418-20. DOI: 10.1002/ajmg.b.30812. View

18.

Pedrosa E, Locker J, Lachman H . Survey of schizophrenia and bipolar disorder candidate genes using chromatin immunoprecipitation and tiled microarrays (ChIP-chip). J Neurogenet. 2009; 23(3):341-52. DOI: 10.1080/01677060802669766. View

19.

Yehuda R, LeDoux J . Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron. 2007; 56(1):19-32. DOI: 10.1016/j.neuron.2007.09.006. View

20.

Kolber B, Muglia L . Defining brain region-specific glucocorticoid action during stress by conditional gene disruption in mice. Brain Res. 2009; 1293:85-90. PMC: 2821940. DOI: 10.1016/j.brainres.2009.03.061. View